Transforming growth factor β is essential for spindle cell conversion of mouse skin carcinoma in vivo: Implications for tumor invasion

Cell Growth and Differentiation

Volumn 9, Issue 5, 1998, Pages 393-404

  Portella, Guiseppe ^a,b   Cumming, Sarah A ^a,c   Liddell, Jennifer ^a   Cui, Wei ^a,d   Ireland, Hazel ^a   Akhurst, Rosemary J ^a,e   Balmain, Allan ^a,e  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e ONYX PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CANCER INVASION; CELL GROWTH; EPITHELIUM CELL; GROWTH INHIBITION; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; SKIN CARCINOMA; SPINDLE CELL CARCINOMA;

EID: 0031817391     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Jouanneau, J., Tucker, G. C., Boyer, B., Valles, A. M., and Thierry, J. P. Epithelial cell plasticity in neoplasia. Bioessays, 3: 525-529, 1991.
2. Valles, A. M., Boyer, B., and Thierry, J. P. Adhesion systems in embryonic epithelial-to-mesenchyme transformation and in cancer invasion and metastasis. Experimentia (Basel), 59 (Suppl.); 17-34, 1991.
3. Mareel, M., Bracke, M., Van Roy, F., and Vakaet, L. Expression of E-cadherin in embryogenetic ingression and cancer invasion. Int. J. Dev. Biol., 37: 227-235, 1993.
4. Liotta, L., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative growth regulation. Cell, 64: 327-336, 1991.
5. Becker, K. F., Atkinson, M. J., Reich, U., Huang, H. H., Siewart, J. R., and Hofler, H. Exon skipping in the E-cadherin gene transcript in metastatic human gastric carcinomas. Hum. Mol. Genet., 2: 803-804, 1993.
6. Becker, K. F., Atkinson, M. J., Reich, U., Becker, I., Mekarda, H., Siewart, J. R., and Hofler, H. E-Cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res., 54: 3845-3852, 1994.
7. Oda, T., Kanai, Y., Oyama, T., Yoshiura, K., Shimoyama, Y., Birchmeier, W., Sugimura, T., and Hirohashi, S. E-Cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 91: 1858-1862, 1994.
8. Risinger, J., Berchuck, A., Kohler, M., and Boyd, J. Mutations of the E-cadherin gene in human gynecologic cancers. Nat. Genet., 7: 98-102, 1994.
9. Blay, J., and Brown, K. Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells. J. Cell. Physiol., 124: 107-112, 1985.
10. Gherardi, E., and Stoker, M. Hepatocyte growth factor-scatter factor: mitogen, motogen and met. Cancer Cells (Cold Spring Harbor), 3: 227-232, 1991.
11. Hartmann, G., Weidner, K. M., Schwarz, H., and Birchmeier, W. The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of ras. J. Biol. Chem., 269: 21936-21939, 1994.
12. Miettinen, P. J., Ebner, R., Lopez, A. R., and Derynck, R. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J. Cell Biol., 127: 2021-2036, 1994.
13. Caulin, C., Scholl, S. G., Frontelo, P., Gamallo, C., and Quintanilla, M. Chronic exposure of cultured transfected mouse epidermal cells to TGF-β1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ., 6: 1027-1035, 1995.
14. Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H., and Reichmann, E. TGF-β1 and Ha-ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev., 10: 2462-2477, 1996.
15. Behrens, J., Vakaet, L, Friis, R., Winterhager, E., Van Roy, F., Mareel, M. M., and Birchmeier, W. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/ β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J. Cell Biol., 120: 757-766, 1993.
16. v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J., 12: 307-314, 1993.
17. Hirst, R. A., Horwitz, A., Buck, C., and Rohrschneider, L. Phosphorylation of the fibronectin receptor complex in cells transformed by oncogenes that encode tyrosine kinases. Proc. Natl. Acad. Sci. USA, 83: 6470-6474, 1986.
18. Pascale, E. B., Maher, P. A., and Singer, S. J. Talin is phosphorylated on tyrosine in chicken embryo fibroblasts transformed by Rous sarcoma virus. Proc. Natl. Acad. Sci. USA, 83: 5507-5511, 1986.
19. Kinsella, A. R., Green, B., Lepts, G. C., Hill, C. L., Bowie, G., and Taylor, B. A. The role of cell-cell adhesion molecule E-cadherin in large bowel cell invasion and metastasis. Br. J. Cancer, 67: 904-909, 1993.
20. Kemp, C. J., Burns, P. A., Brown, K., Nagase, H., and Balmain, A. Transgenic approaches to the analysis of ras and p53 function in multistage carcinogenesis. Cold Spring Harbor Symp. Quant. Biol., 59: 427-434, 1994.
21. Yuspa, S. H. The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis-thirty-third G. H. A. Clowes Memorial Award Lecture. Cancer Res., 54: 1178-1189, 1994.
22. Buchmann, A., Ruggeri, B., Klein-Szanto, A. J. P., and Balmain, A. Progression of squamous carcinoma cells to spindle carcinoma of the mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. Cancer Res., 51: 4097-4101, 1991.
23. Stoler, A., Stenback, F., and Balmain, A. The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. J. Cell Biol., 122: 1103-1117, 1993.
24. Battifora, H. B. Spindle cell carcinoma: ultrastructural evidence of squamous origin and collagen production by tumor cells. Cancer (Phila.), 4: 919-929.
25. Evans, H. L., and Smith, J. L. Spindle cell carcinoma and carcinoma-like tumors of the skin: a comparative study of 38 cases. Cancer (Phila.), 45: 2687-2697, 1980.
26. Lenventon, G. S., and Evans, H. L. Sarcomatid squamous cell carcinoma of the mucous membranes of the head and neck: a clinicopathological study of 20 cases. Cancer (Phila.), 48: 994-1003, 1981.
27. Cui, W., Fowlis, D. J., Bryson, S., Duffie, E., Ireland, H., Balmain, A., and Akhurst, R. J. TGFβ1 inhibits the formation of benign skin tumours but enhances progression to invasive spindle cell carcinomas in transgenic mice. Cell, 86: 531-542, 1996.
28. Roberts, A. B., and Sporn, M. B. The transforming growth factor-βs. In: M. B. Sporn and A. B. Roberts (eds.), Peptide Growth Factors and Their Receptors, pp. 419-472. Heidelberg, Germany: Springer Verlag, 1990.
29. 6 heterodimer in normal human keratinocytes: implications for wound healing. J. Cell Biol., 129: 853-865, 1995.
30. Cui, W., and Akhurst, R. J. Transforming growth factors β: biochemistry and biology in vitro and in vivo. In: C. Bondy and D. LeRoith (eds.), Growth Factors and Cytokines in Health and Disease. Greenwich, CT: JAI Press, 1996.
31. Hosobuchi, M., and Stampfer, M. R. Effects of transforming growth factor β on growth of human mammary epithelial cells in culture. In Vitro Cell Dev. Biol., 25: 705-713, 1989.
32. Bremner, R., and Balmain, A. Genetic changes in skin tumor progression: correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell, 61: 407-417, 1990.
33. Liddell, J. Genetic and biochemical factors involved in progression of mouse skin tumours (Thesis). Glasgow, United Kingdom: Glasgow University, 1995.
34. Welch, D. R., Fabra, A., and Nakajima, M. Transforming growth factor β stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc. Natl. Acad. Sci. USA, 87: 7678-7682, 1990.
35. Arteaga, C., Hurd, S. D., Winnier, A. R., Johnson, M. D., Fendly, B. M., and Forbes, J. T. Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer activity. J. Clin. Invest., 92: 2569-2576, 1993.
36. Burns, P. A., Kemp, C. J., Gannon, J. V., Lane, D. P., Bremner, R., and Balmain, A. Loss of heterozygosity and mutational analysis of the p53 gene in skin tumours of inter-specific hybrid mice. Oncogene, 6: 2363-2639, 1991.
37. Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D., and Birchmeier, W. E-Cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol., 113: 173-185, 1991.
38. Navarro, P., Gomez, M., Pizarro, A., Gamallo, C., Quintanilla, M., and Cano, A. A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J. Cell Biol., 115: 517-533, 1991.
39. Massagué, J. Receptors for the TGFβ family. Cell, 69: 1067-1070, 1992.
40. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1994.
41. Haddow, S., Fowlis, D. J., Parkinson, K., Akhurst, R. J., and Balmain, A. Loss of growth control by TGFβ occurs at a late stage of mouse carcinogenesis and is independent of ras gene activation. Oncogene, 6: 1465-1470, 1991.
42. Lin, H. Y., Wang, X., Ng, E. E., Weinberg, R. A., and Lodish, H. F. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992.
43. Zentella, A., Weis, F. M. B., Ralph, D. A., Laiho, M., and Massagué, J. Early gene responses to transforming growth factor-β in cells lacking growth-suppressive RB function. Mol. Cell. Biol., 11: 4952-4958, 1991.
44. Geiser, A. G., Burmester, J. K., Webbink, R., Roberts, A. B., and Sporn, M. B. Inhibition of growth by transforming growth factor-β following fusion of two non-responsive human carcinoma cell lines. J. Biol. Chem., 267: 2588-2593, 1992.
45. Chen, R., Ebner, R., and Derynck, R. Inactivation of the type II receptor reveals two distinct pathways for diverse TGFβ activities. Science (Washington DC), 260: 1335-1338, 1993.
46. Stampfer, M. R., Yaswen, P., Alhadeff, M., and Hosoda, J. TGFβ induction of extracellular matrix associated proteins in normal and transformed human mammary epithelial cells in culture is independent of growth effects. J. Cell. Physiol., 155: 210-221, 1993.
47. Wieser, R., Attisano, L., Wrana, J. L., and Massagué, J. Signaling activity of transforming growth factor β type II receptors lacking specific domains in the cytoplasmic region. Mol. Cell. Biol., 13: 7239-7247, 1993.
48. Okadome, T., Yamashita, H., Franzen, P., Moren, A., Heldin, C., and Miyazono, K. Distinct roles of the intracellular domains of transforming growth factor-β type I and type II receptors in signal transduction. J. Biol. Chem., 269: 30753-30756, 1994.
49. Vivien, D., Attisano, L., Wrana, J. L., and Massagué, J. Signaling activity of homologous and heterologous transforming growth factor-β receptor kinase complexes. J. Biol. Chem., 270: 7134-7141, 1995.
50. Centrella, M., Casinghino, S., Kim, J., Pham, T., Rosen, V., Wozney, J., and McCarthy, T. L. Independent changes in type I and type II receptors for transforming growth factor β induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype. Mol. Cell. Biol., 15: 3273-3281, 1995.
51. Cui, W., Fowlis, D. J., Cousins, F. M., Duffie, E., Bryson, S., Balmain, A., and Akhurst, R. J. Concerted action of TGFβ1 and its type II receptor in control of epidermal homeostasis in transgenic mice. Genes Dev., 9: 945-955, 1995.
52. Munger, K., Pietenpol, J. A., Pittelkow, M. R., Holt, J. L., and Moses, H. L. Transforming growth factor β1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes. Cell Growth Differ., 3: 291-298, 1992.
53. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
54. Reynisdottir, I., Polyak, K., Iavarone, A., and Massagué, J. Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9: 1831-1845, 1995.
55. Lagna, G., Hata, A., Hemmati-Brivanlou, A., and Massagué, J. Partnership between DPC4 and SMAD proteins in TGF-β signalling pathways. Nature (Lond.), 383: 832-836, 1996.
56. Zhang, Y., Feng, X., Wu, R., and Derynck, R. Receptor-associated Mad homologues synergize as effectors of the TGF-β response. Nature (Lond.), 383: 168-172, 1996.
57. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., and Vogelstein, B. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1276-1277, 1995.
58. Park, K., Kim, S., Bang, Y., Park, J., Kim, N. K., Roberts, A. B., and Sporn, M. B. Genetic changes in the transforming growth factor β (TGFβ) type II receptor in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGFβ. Proc. Natl. Acad. Sci. USA, 91: 8772-8776, 1994.
59. Garrigue-Antar, L., Munoz-Antonia, T., Antonia, S. J., Gesmonde, J., Vellucci, V. F., and Reiss, M. Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous carcinoma cells. Cancer Res., 55: 3982-3987, 1995.
60. Mathew, S., Murty, V. V. V. S., Cheifetz, S., George, D., Massagué, J., and Chaganti, R. S. K. Transforming growth factor receptor gene TGFBR2 maps to human chromosome 3p22. Genomics, 20: 114-115, 1994.
61. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
62. Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4 a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-353, 1996.
63. Derynck, R., Goeddel, D. V., Ullrich, A., Gutterman, J. U., Williams, R. D., Bringman, T. S., and Berger, W. H. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res., 47: 707-712, 1987.
64. Dickson, R. B., Kasid, A., Huff, K. K., Bates, S. E., Knabbe, C., Bronzert, D., Gelmann, E. P., and Lippman, M. E. Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 β-estradiol or v-Ha-ras oncogene. Proc. Natl. Acad. Sci. USA, 84: 837-841, 1987.
65. Gomella, L. G., Sargent, E. R., Wade, T. P., Anglard, P., Linehan, W. M., and Kasid, A. Expression of transforming growth factor α in normal adult kidney and enhanced expression of transforming growth factors α and β in renal cell carcinoma. Cancer Res., 49: 6972-6975, 1989.
66. Arrick, B. A., Korc, M., and Derynck, R. Differential regulation of three transforming growth factor β species in human breast cancer cell lines by estradiol. Cancer Res., 50: 299-303, 1990.
67. Steiner, M. S., and Barrack, E. R. Transforming growth factor-β1 overproduction in prostate cancer: effects on growth in vivo and in vitro. Mol. Endocrinol., 6: 15-25, 1992.
68. Arteaga, C. L., Carty-Dugger, T., Moses, H. L., Hurd, S. D., and Pietenpol, J. A. Transforming growth factor β1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice. Cell Growth Differ., 4: 193-201, 1993.
69. Chang, H. L., Gillett, N., Figaro, I., Lopez, A. R., Palladino, M. A., and Derynck, R. Increased transforming growth factor β expression inhibits cell proliferation in vitro yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res., 53: 4391-4398, 1993.
70. Huang, F., Newman, E., Theodorescu, D., Kerbel, R. S., and Friedman, E. Transforming growth factor β1 (TGFβ1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGFβ1 antisense expression plasmid. Cell Growth Differ., 6: 1635-1642, 1995.
71. Fowlis, D. J., Cui, W., Johnson, S. A., Balmain, A., and Akhurst, R. J. Altered epidermal growth control in vivo in transgenic mice expressing TGFβ1 from an inducible keratin gene promoter. Cell Growth Differ., 7: 679-687, 1996.
72. Bubb, V. J., Curtis, L. J., Cunningham, C., Dunlop, M. G., Carothers, A. D., Morris, R. G., White, S., Bird, C. C., and Wylie, A. H. Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene, 12: 2641-2649, 1996.
73. Border, W. A., and Noble, N. A. Targeting TGF-β for treatment of disease. Nat. Med., 1: 1000-1001, 1995.
74. Marshall, E. Reanalysis confirms results of "tainted" study: long term tamoxifen trial halted. Science (Washington DC), 270: 1562, 1995.
75. Grainger, D. J., Witchell, C. M., and Metcalfe, J. C. Tamoxifen elevates transforming growth factor-β and suppresses diet-induced formation of lipid lesions in mouse aorta. Nat. Med., 1: 1067-1073, 1995.
76. Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.